Fluticasone Propionate/Salmeterol MDPI (AirDuo RespiClick®): A Review in Asthma
Sign Up to like & getrecommendations! Published in 2018 at "Clinical Drug Investigation"
DOI: 10.1007/s40261-018-0644-2
Abstract: The novel, easy-to-use, breath-actuated fluticasone propionate/salmeterol multidose dry powder inhaler (MDPI) (AirDuo RespiClick®) was recently approved in the USA for twice-daily treatment of asthma in patients aged ≥ 12 years. This inhaled corticosteroid (ICS) and long-acting… read more here.
Keywords: fluticasone propionate; propionate salmeterol; salmeterol mdpi; mdpi ... See more keywords
Safety, efficacy, and dose response of fluticasone propionate delivered via the novel MDPI in patients with severe asthma: A randomized, controlled, dose-ranging study
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Asthma"
DOI: 10.1080/02770903.2016.1242137
Abstract: ABSTRACT Objective: Evaluate fluticasone propionate (Fp) using a novel, inhalation-driven, multidose dry powder inhaler (MDPI) in patients with severe persistent asthma, versus placebo MDPI and Fp dry powder inhaler (DPI). Methods: Patients with persistent asthma… read more here.
Keywords: patients severe; safety; mdpi; fluticasone propionate ... See more keywords
In Vitro Performance of the Wixela Inhub Inhaler Using Severe Chronic Obstructive Pulmonary Disease Patient Inhalation Profiles.
Sign Up to like & getrecommendations! Published in 2021 at "Journal of aerosol medicine and pulmonary drug delivery"
DOI: 10.1089/jamp.2021.0017
Abstract: Background: Wixela Inhub (trademarks of Viatris, Inc.) is a dry powder inhaler (DPI) that delivers a fixed-dose combination of fluticasone propionate and salmeterol and is approved as a generic equivalent to Advair Diskus (trademarks of… read more here.
Keywords: inhaler; fluticasone propionate; wixela inhub; inhalation profiles ... See more keywords
No dose effect observed with chronic fluticasone propionate on growth velocity in children
Sign Up to like & getrecommendations! Published in 2020 at "Pediatric Allergy and Immunology"
DOI: 10.1111/pai.13378
Abstract: Inhaled corticosteroid (ICS) therapy is recommended for most children with asthma irrespective of severity. Although this risks growth suppression, the benefit/risk profile is considered favorable.1,2 The effects of ICS on growth have mainly been evaluated… read more here.
Keywords: chronic fluticasone; effect observed; fluticasone propionate; observed chronic ... See more keywords
P346 Comparing of monitoring successfull therapy for two drugs in obstructive pulmonary disease at children aged one to four years
Sign Up to like & getrecommendations! Published in 2017 at "Archives of Disease in Childhood"
DOI: 10.1136/archdischild-2017-313273.434
Abstract: Introduction Monitoring the success of treatment with inhaled corticosteroid fluticasone propionate type comparing with inbibitor of leukotriene, montelukast in preschool children is an everyday topic. Control of chronic obstructive pulmonary disease is one of the… read more here.
Keywords: age; obstructive pulmonary; disease; fluticasone propionate ... See more keywords
Enhanced Optimal Parameter-Based Nebulizer Design for Flow Analysis of Fluticasone Propionate
Sign Up to like & getrecommendations! Published in 2023 at "AAPS PharmSciTech"
DOI: 10.1208/s12249-023-02548-1
Abstract: A jet nebulizer sprays a fine mist or aerosol directly into the lungs to reduce inflammation, expand airways, and make breathing easier for respiratory patients. Asthma, COPD, emphysema, and cystic fibrosis are treated with jet… read more here.
Keywords: output; parameter; jet; fluticasone propionate ... See more keywords
Fluticasone propionate as a potential treatment for COVID-19.
Sign Up to like & getrecommendations! Published in 2022 at "Drugs of today"
DOI: 10.1358/dot.2022.58.5.3381591
Abstract: Outpatient treatment options for mild to moderate COVID-19 are severely limited. While many therapeutic options have been proposed, very few have demonstrated the appropriate safety and efficacy to warrant approval by national or international regulatory… read more here.
Keywords: propionate potential; potential treatment; treatment covid; treatment ... See more keywords
Bacterial regulation of macrophage bacterial recognition receptors in COPD are differentially modified by budesonide and fluticasone propionate
Sign Up to like & getrecommendations! Published in 2019 at "PLoS ONE"
DOI: 10.1371/journal.pone.0207675
Abstract: Rationale Patients with COPD have an increased risk for community-acquired pneumonia, which is further increased by inhaled corticosteroids. Objective To assess effects of the corticosteroids, budesonide and fluticasone propionate, on macrophage bacterial responses in COPD.… read more here.
Keywords: copd; fluticasone propionate; budesonide fluticasone; bacterial recognition ... See more keywords
Evaluation of in vitro Penetration of Fluticasone Propionate from MP-AzeFlu and Fluticasone Propionate Nasal Spray Through EpiAirway™606 Tissues Using Vertical Diffusion Cells
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Asthma and Allergy"
DOI: 10.2147/jaa.s238421
Abstract: Purpose Most patients with allergic rhinitis (AR) have moderate-to-severe disease, requiring complete and prompt relief when symptoms occur. The time course of fluticasone propionate (FP) penetration into nasal tissues after intranasal administration is not well… read more here.
Keywords: fluticasone propionate; penetration; nasal spray; spray ... See more keywords
Fluticasone propionate and fluticasone propionate/salmeterol multidose dry powder inhalers compared with placebo for persistent asthma.
Sign Up to like & getrecommendations! Published in 2017 at "Allergy and asthma proceedings"
DOI: 10.2500/aap.2017.38.4069
Abstract: BACKGROUND A novel, inhalation-driven, multidose dry powder inhaler (MDPI) has been developed, which allows for lower doses of fluticasone propionate (Fp) and Fp/salmeterol (FS) for the treatment of patients with asthma. OBJECTIVE This phase III,… read more here.
Keywords: end points; asthma; fluticasone propionate; mdpi ... See more keywords
Treatment with azelastine hydrochloride and fluticasone propionate in a single delivery device of young children and adolescents with allergic rhinitis.
Sign Up to like & getrecommendations! Published in 2020 at "Allergy and asthma proceedings"
DOI: 10.2500/aap.2020.41.200034
Abstract: Background: Allergic rhinitis (AR) is the most common chronic noncommunicable disease worldwide that affects any age during the human life span but raises particular concerns among the parents and caregivers of the children who are… read more here.
Keywords: allergic rhinitis; fluticasone; delivery; hydrochloride fluticasone ... See more keywords